4 Smallcap Quarterly Revenue Below Rs 500 Crore Stocks to Watch for Future Multibagger Potential: Happy Forgings, Vijaya Diagnostic, Metropolis and Saregama

Quarterly revenue below Rs 500 crore stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Happy Forgings, Vijaya Diagnostic, Metropolis and Saregama meet that test, with market caps from Rs 9,972 crore to Rs 17,755 crore and Happy Forgings offering the fastest profit growth, 20.66% a year since FY22. Each of these companies has a market capitalisation below Rs 30,000 crore and quarterly revenue below Rs 500 crore, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a market capitalisation below Rs 30,000 crore and quarterly revenue below Rs 500 crore, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap below Rs 30,000 crore. Investors screening quarterly revenue below Rs 500 crore stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Quarterly Revenue Below Rs 500 Crore Stocks and Why Do They Attract Multibagger Interest?

Quarterly revenue below Rs 500 crore stocks are shares of smaller companies with a quarterly revenue base below Rs 500 crore, a small base from which steady growth can add up quickly. The four here cover forgings, imaging diagnostics, pathology diagnostics and music and media.

A small revenue base leaves a long runway for growth, and rising profit from here shows that the company is scaling with discipline. For quarterly revenue below Rs 500 crore stocks, both FY26 and the latest quarter showed growth. A sensible way to study quarterly revenue below Rs 500 crore stocks is to look at profit growth, returns and valuation side by side. Below, each of quarterly revenue below Rs 500 crore stocks gets its own breakdown of growth, returns and valuation. Treat quarterly revenue below Rs 500 crore stocks as a research list, since share prices and rankings change with every earnings season.

Quarterly Revenue Below Rs 500 Crore Stocks at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 28 October 2026. Saregama has the lowest PE of the group at 45.09, while Vijaya Diagnostic posts the highest return on equity at 18.07%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Happy Forgings	1,784.60	17,755	54.23	52.03	14.17%	0.15	888.75 to 2,470.00
Vijaya Diagnostic Centre	1,442.80	15,004	80.04	60.75	18.07%	0.44	848.00 to 1,593.60
Metropolis Healthcare	551.20	11,547	56.91	60.75	12.56%	0.15	453.50 to 733.00
Saregama India	523.95	9,972	45.09	26.08	12.23%	0.04	307.05 to 574.50

Happy Forgings: 20.66% Profit CAGR Since FY22

Happy Forgings makes complex, safety-critical forged and machined components for commercial vehicles, passenger vehicles, tractors and industrial customers. It reported FY26 revenue of Rs 1,577.15 crore, up 9.04% year on year, and net profit of Rs 301.63 crore, up 12.78%. Net profit has compounded at 20.66% a year since FY22, while revenue has grown 16.16% a year. Operating margin was 32.43% in FY26. The debt-to-equity ratio is 0.15, which keeps interest costs low.

In the June 2026 quarter, revenue rose 26.46% to Rs 460.50 crore and net profit grew 39.23% to Rs 91.46 crore. The share price is up 97.54% over the past year. Foreign investors raised their holding from 2.02% in September 2025 to 2.37% in September 2026. The stock trades at a PE of 54.23 against an industry PE of 52.03, with a return on equity of 14.17%.

Vijaya Diagnostic: Quarterly Profit Up 37.60%

Vijaya Diagnostic Centre runs diagnostic centres offering pathology and radiology services, with a strong base in South India. It reported FY26 revenue of Rs 835 crore, up 19.34% year on year, and net profit of Rs 172.98 crore, up 20.30%. Net profit has compounded at 11.81% a year since FY22, while revenue has grown 15.13% a year. Operating margin was 43.94% in FY26. The debt-to-equity ratio is 0.44.

The stock trades at a PE of 80.04 against an industry PE of 60.75, with a return on equity of 18.07%. In the June 2026 quarter, revenue rose 22.76% to Rs 239.51 crore and net profit grew 37.60% to Rs 53.10 crore. The share price has gained 141.31% over five years and 38.44% over the past year. Domestic institutions raised their holding from 25.34% in September 2025 to 32.50% in September 2026.

Metropolis: Revenue Up 24.15% in FY26

Metropolis Healthcare provides pathology and diagnostic services through a network of laboratories, clinical labs and collection centres. It reported FY26 revenue of Rs 1,671.43 crore, up 24.15% year on year, and net profit of Rs 191.18 crore, up 31.39%. Revenue has compounded at 7.62% a year since FY22. Operating margin was 25.63% in FY26. The debt-to-equity ratio is 0.15, which keeps interest costs low.

In the June 2026 quarter, revenue rose 15.69% to Rs 455.32 crore and net profit grew 25.70% to Rs 56.88 crore. Domestic institutions raised their holding from 32.40% in June 2025 to 35.12% in June 2026. The stock trades at a PE of 56.91 against an industry PE of 60.75, below the sector average, with a return on equity of 12.56%.

Saregama: Debt-to-Equity of 0.04

Saregama India owns one of the largest Indian music catalogues and earns from music licensing, film and series production and consumer products such as Carvaan. It reported FY26 revenue of Rs 1,026.88 crore and net profit of Rs 206.22 crore, up 0.97%. Net profit has compounded at 5.83% a year since FY22, while revenue has grown 13.86% a year. Operating margin was 37.69% in FY26. The debt-to-equity ratio is 0.04, which keeps interest costs low.

The stock trades at a PE of 45.09 against an industry PE of 26.08, with a return on equity of 12.23%. In the June 2026 quarter, revenue rose 21.18% to Rs 267.81 crore and net profit grew 42.10% to Rs 51.88 crore. Domestic institutions raised their holding from 5.22% in June 2025 to 8.60% in June 2026.

Quarterly Revenue Below Rs 500 Crore Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these quarterly revenue below Rs 500 crore stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	4-Year Revenue CAGR	Latest Quarter Revenue Growth	Net Profit Growth (YoY)	Operating Margin (Latest Quarter)
Happy Forgings	1,577.15	301.63	16.16%	26.46%	12.78%	33.81%
Vijaya Diagnostic	835	172.98	15.13%	22.76%	20.30%	46.35%
Metropolis	1,671.43	191.18	7.62%	15.69%	31.39%	25.83%
Saregama	1,026.88	206.22	13.86%	21.18%	0.97%	36.54%

Check the Univest Screener for live data on these quarterly revenue below Rs 500 crore stocks

Institutional Holding in Happy Forgings, Vijaya Diagnostic, Metropolis and Saregama

Institutional holding shows who is backing these quarterly revenue below Rs 500 crore stocks alongside the promoter. The table uses the latest reported quarter for each. Metropolis has the deepest institutional backing, with FII and DII together holding 46.15% as of June 2026. Domestic institutions increased their holding over the past year in Vijaya Diagnostic (from 25.34% to 32.50%), Metropolis (from 32.40% to 35.12%) and Saregama (from 5.22% to 8.60%).

Stock	Promoter	FII	DII	Public	Quarter
Happy Forgings	78.44%	2.37%	14.93%	4.26%	September 2026
Vijaya Diagnostic	52.46%	10.66%	32.50%	4.38%	September 2026
Metropolis	48.86%	11.03%	35.12%	4.99%	June 2026
Saregama	60.84%	11.50%	8.60%	19.06%	June 2026

Risks to Weigh in Quarterly Revenue Below Rs 500 Crore Stocks

Being careful with quarterly revenue below Rs 500 crore stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Saregama trades at a PE of 45.09 against an industry PE of 26.08, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Quarterly Revenue Below Rs 500 Crore Stocks

Picking from quarterly revenue below Rs 500 crore stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (26.08 to 60.75) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Happy Forgings, Vijaya Diagnostic, Metropolis and Saregama live prices.

Conclusion

Among quarterly revenue below Rs 500 crore stocks, Happy Forgings stands out for the fastest profit growth, 20.66% a year since FY22, Vijaya Diagnostic for the highest return on equity at 18.07%, Metropolis for 24.15% revenue growth in FY26 and Saregama for the strongest latest-quarter profit growth at 42.10%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing quarterly revenue below Rs 500 crore stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Quarterly Revenue Below Rs 500 Crore Stocks to Watch

Which are the best quarterly revenue below Rs 500 crore stocks to watch for multibagger potential?

Ans. Happy Forgings, Vijaya Diagnostic, Metropolis and Saregama are the 4 names this list highlights, with market caps of Rs 17,755 crore, Rs 15,004 crore, Rs 11,547 crore and Rs 9,972 crore respectively. Happy Forgings is notable for the fastest profit growth, 20.66% a year since FY22. Vijaya Diagnostic stands out for the highest return on equity at 18.07%. Metropolis offers 24.15% revenue growth in FY26. Saregama brings the strongest latest-quarter profit growth at 42.10%. These are watchlist names for quarterly revenue below Rs 500 crore stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is Vijaya Diagnostic a good stock for long-term investors?

Ans. Vijaya Diagnostic has a return on equity of 18.07%, a PE of 80.04 against an industry PE of 60.75 and a market cap of Rs 15,004 crore. Net profit has compounded at 11.81% a year since FY22, and FY26 revenue rose 19.34% while June 2026 quarter net profit grew 37.60%. Long-term returns in quarterly revenue below Rs 500 crore stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Happy Forgings become a multibagger from here?

Ans. Happy Forgings has a market cap of Rs 17,755 crore. A multibagger outcome in quarterly revenue below Rs 500 crore stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 20.66% a year since FY22, and FY26 revenue rose 9.04%. At a PE of 54.23 against an industry PE of 52.03, valuation should be checked against that growth before investing.

What is the market cap of Happy Forgings, Vijaya Diagnostic, Metropolis and Saregama?

Ans. As of 28 October 2026, Happy Forgings has a market cap of Rs 17,755 crore, Vijaya Diagnostic has a market cap of Rs 15,004 crore, Metropolis has a market cap of Rs 11,547 crore and Saregama has a market cap of Rs 9,972 crore. All of them qualify as smallcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on quarterly revenue below Rs 500 crore stocks.

What are the risks of investing in quarterly revenue below Rs 500 crore stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Saregama trades at a PE of 45.09 against an industry PE of 26.08, so earnings growth needs to hold up.

Why is Saregama trading at a PE of 45.09?

Ans. Saregama's PE of 45.09 compares with an industry PE of 26.08. The market is paying a premium for latest-quarter profit growth of 42.10%, which also means the stock is more sensitive if growth slows. Investors in quarterly revenue below Rs 500 crore stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Happy Forgings, Vijaya Diagnostic, Metropolis and Saregama?

Ans. As of the latest reported quarter, FII and DII together hold 17.30% of Happy Forgings (2.37% and 14.93%), 43.16% of Vijaya Diagnostic (10.66% and 32.50%), 46.15% of Metropolis (11.03% and 35.12%) and 20.10% of Saregama (11.50% and 8.60%). Rising institutional holding is a useful signal in quarterly revenue below Rs 500 crore stocks, though it should be read with earnings trends rather than on its own.